GlassScriptPhysician profile
Lior Haim
NPI 1518013358
$1,966.99
in general payments reported to CMS, 2019-2025
21 companies · $227 in 2025
The $227 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $576 · 2020: $97.01 · 2021: $192 · 2022: $270 · 2023: $293 · 2024: $312 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $831.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $831.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $406.75 | 2019-2025 | Tryptyr, Eysuvis, Simbrinza |
| Ocular Therapeutix, INC. | $293.57 | 2022-2024 | Dextenza |
| Sight Sciences, INC. | $147.24 | 2019-2023 | Tearcare System |
| Bausch & Lomb Americas INC. | $135.73 | 2022-2025 | Vyzulta, Xiidra, Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $134.88 | 2019-2021 | |
| Allergan, INC. | $125.79 | 2019-2022 | |
| Apellis Pharmaceuticals, INC. | $104.77 | 2023 | Syfovre |
| Sun Pharmaceutical Industries INC. | $86.22 | 2019-2025 | |
| Kala Pharmaceuticals, INC. | $76.57 | 2019-2021 | |
| Abbvie INC. | $68.10 | 2022-2023 | |
| Aerie Pharmaceuticals, INC. | $67.66 | 2019-2021 | |
| Horizon Therapeutics Plc | $66.85 | 2022-2023 | Tepezza |
| Oyster Point Pharma, INC. | $50.40 | 2022-2025 | Tyrvaya |
| Novartis Pharmaceuticals Corporation | $34.53 | 2022 | |
| Omeros Corporation | $31.51 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $29.23 | 2025 | Oxervate |
| Harrow Eye, LLC | $26.93 | 2025 | Vevye |
| Akorn, INC. | $24.36 | 2019 | |
| Rayner Intraocular Lenses Limited | $21.14 | 2024 | Omidria |
| Johnson & Johnson Vision Care, INC. | $18.83 | 2023 | Acuvue |
| Abb Con-Cise Optical Group LLC | $15.93 | 2023 | Spectacle Lenses, Contact Lens |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lior Haim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.